Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2013
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013169964A1 Heteroaryl compounds and methods of use thereof
11/14/2013WO2013169907A1 Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof
11/14/2013WO2013169889A1 Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
11/14/2013WO2013169622A1 Azetidine derivatives as antiparasitic agents
11/14/2013WO2013168927A2 Novel compound and organic electroluminescent device comprising same
11/14/2013WO2013168688A1 Organic electroluminescence element, illumination device, and display device
11/14/2013WO2013167552A1 Method for the preparation of triazole compounds
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013US20130303763 Methods and compositions for the treatment of necrotizing enterocolitis
11/14/2013US20130303579 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
11/14/2013US20130303571 New compounds
11/14/2013US20130303567 Small molecule inhibitors of parp activity
11/14/2013US20130303559 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
11/14/2013US20130303551 Pyrimidinone derivatives as fatty acid synthase inhibitors
11/14/2013US20130303547 HCV Protease Inhibitors and Uses Thereof
11/14/2013US20130303538 4-Tolyl-ethynyl-octahydro-indole-1-ester derivatives
11/14/2013US20130303525 Kappa opioid receptor agonists
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303505 Tgr5 agonists
11/14/2013US20130303497 Deuterated 5-ht1a receptor agonists
11/14/2013US20130303493 Triazole Compounds that Modulate HSP90 Activity
11/14/2013US20130303492 3,5-diaminopyrazole kinase inhibitors
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/14/2013US20130303368 New compositions and methods for controlling nematode pests
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/13/2013EP2662368A1 Aromatic heterocycle derivative and organic electroluminescent element using same
11/13/2013EP2662367A1 Novel indole or indazole derivative or salt thereof
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2662365A1 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2662356A1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661432A1 Pyrrolidine derivatives as nk3 antagonists
11/13/2013EP2661425A2 Hedgehog antagonists having zinc binding moieties
11/13/2013CN103391935A Diaminopyrimidine derivatives and processes for the preparation thereof
11/13/2013CN103387571A Bi-imidazole type benzimidazole ionic liquid and preparation method thereof
11/13/2013CN103387570A Preparation method of rizatriptan benzoate
11/13/2013CN102105451B Glucokinase activators
11/13/2013CN101883764B Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/13/2013CN101778840B Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
11/13/2013CN101687844B Imidazole derivatives as CCR2 receptor antagonists
11/13/2013CN101679279B Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
11/13/2013CN101560204B Antihypertensive drug cilazapril intermediate and preparation method thereof
11/12/2013US8580970 Copper-catalysed ligation of azides and acetylenes
11/12/2013US8580959 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580834 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/12/2013US8580786 Triazine derivatives and their therapeutical applications
11/12/2013US8580785 Insecticides
11/12/2013US8580781 Pyridazinone derivatives
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/12/2013US8580778 Substituted dihydropyrazolones and their use
11/12/2013US8580398 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
11/12/2013US8580391 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/12/2013CA2752981C Indole derivatives as crth2 receptor antagonists
11/12/2013CA2680017C Compositions and methods relating to novel compounds and targets thereof
11/12/2013CA2623822C 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
11/07/2013WO2013165796A1 Crystalline form of a pyridyl-piperazinyl hepatitis c virus inhibitor
11/07/2013WO2013165192A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164838A1 Heterocyclic compounds and their use for treatment of diabetes, obesity or related disorders
11/07/2013WO2013164802A1 Complement pathway modulators and uses thereof
11/07/2013WO2013164337A1 New compounds and new use
11/07/2013WO2013164321A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
11/07/2013WO2013164295A1 Substituted pyrazole-containing compounds and their use as pesticides
11/07/2013WO2013164245A1 Plant growth regulating compounds
11/07/2013US20130296575 Sunitinib and salts thereof and their polymorphs
11/07/2013US20130296567 Bisazole-based compound and group viii transition metal complex
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
11/07/2013US20130296377 Complement pathway modulators and uses thereof
11/07/2013US20130296355 Glucagon receptor modulators
11/07/2013US20130296339 Isoindolinone derivatives
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/07/2013US20130296327 Substituted heterocylic compounds
11/07/2013US20130296322 Serotonin reuptake inhibitors
11/07/2013US20130296320 Novel bicyclic compound or salt thereof
11/07/2013US20130296318 Compounds and compositions as protein kinase inhibitors
11/07/2013US20130296311 Inhibitors of hcv ns5a
11/07/2013US20130296304 Tricyclic fused ring inhibitors of hepatitis c
11/07/2013US20130295049 Linked dibenzimidazole antivirals
11/06/2013EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/06/2013EP2660238A1 Compounds for the prevention and treatment of cardiovascular disease
11/06/2013EP2658859A2 Macrocyclic hepatitis c serine protease inhibitors
11/06/2013EP2658844A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
11/06/2013CN103384712A Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/06/2013CN103384664A Anti-viral compounds
11/06/2013CN103382199A Preparation method of N-alkyl-bismaleimide
11/06/2013CN103382180A Preparation method for organic phosphor material ligand of same category and with hole transfer function
11/06/2013CN103382174A Cyclopropyl amine derivatives as histamin h3 receptor modulators
11/06/2013CN102369197B 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as ADP receptor antagonists
11/06/2013CN102304108B Five-membered heterocyclic dicarbonyl derivative and application thereof on multi-drug resistant bacteria
11/06/2013CN101899006B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
11/06/2013CN101522659B Fungicide N-cycloalkyl-carboxamide, thiocarboxamide and N-substituted-carboximidamide derivatives
11/06/2013CN101448822B Substituted pyrazolopyrimidines
11/06/2013CN101287724B Solid salt forms of a pyrrole substituted 2-indolinone
11/06/2013CN101010302B Sigma receptor inhibitors
11/05/2013US8575360 Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 626